Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934

David M. Ashley, Thomas E. Merchant, Douglas Strother, Tianni Zhou, Patricia Duffner, Peter C. Burger, Douglas C. Miller, Nancy Lyon, Melanie J. Bonner, Michael Msall, Allen Buxton, Russell Geyer, Larry E. Kun, Lee Coleman, Ian F. Pollack

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

Purpose: P9934 was a prospective trial of systemic chemotherapy, second surgery, and conformal radiation therapy (CRT) limited to the posterior fossa and primary site for children between 8 months and 3 years old with nonmetastatic medulloblastoma. The study was open from June 2000 until June 2006. Patients and Methods: After initial surgery, children received four cycles of induction chemotherapy, followed by age- and response-adjusted CRT to the posterior fossa (18 or 23.4 Gy) and tumor bed (cumulative 50.4 or 54 Gy) and maintenance chemotherapy. Neurodevelopmental outcomes were evaluated and event-free survival (EFS) results were directly compared with a previous study of multiagent chemotherapy without irradiation (Pediatric Oncology Group [POG] trial 9233). Results: Seventy-four patients met eligibility requirements. The 4-year EFS and overall survival probabilities were 50% ± 6% and 69% ± 5.5%, respectively, which compared favorably to the results from POG 9233. Analysis showed that the desmoplastic/nodular subtype was a favorable factor in predicting survival. Our 4-year EFS rate was 58% ± 8% for patients with desmoplasia. Whereas seven of 10 patients who had disease progression before CRT had primary-site failure, 15 of 19 patients who progressed after CRT had distant-site failure. Neurodevelopmental assessments did not show a decline in cognitive or motor function after protocol-directed chemotherapy and CRT. Conclusion: The addition of CRT to postoperative chemotherapy in young children with nonmetastatic medulloblastoma increased event-free survival compared with the use of postoperative chemotherapy alone. Future studies will use histopathologic typing (desmoplastic/nodular versus nondesmoplastic/nodular) to stratify patients for therapy by risk of relapse.

Original languageEnglish (US)
Pages (from-to)3181-3186
Number of pages6
JournalJournal of Clinical Oncology
Volume30
Issue number26
DOIs
StatePublished - Sep 10 2012

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ashley, D. M., Merchant, T. E., Strother, D., Zhou, T., Duffner, P., Burger, P. C., Miller, D. C., Lyon, N., Bonner, M. J., Msall, M., Buxton, A., Geyer, R., Kun, L. E., Coleman, L., & Pollack, I. F. (2012). Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934. Journal of Clinical Oncology, 30(26), 3181-3186. https://doi.org/10.1200/JCO.2010.34.4341